慢阻肺长期使用吸入性糖皮质激素与骨折风险
该研究基于魁北克医疗数据库1990-2005年慢阻肺队列(240,110例),随访至2007年首次髋部或上肢骨折。嵌套病例对照分析显示,任何ICS使用与骨折风险无关,但每日剂量≥1,000 μg氟替卡松等效且使用>4年时骨折风险轻度增加,且风险增加无性别差异。
要点
- 慢阻肺患者任何ICS使用不增加骨折风险(RR 1.00)。
- 高剂量长疗程ICS(>4年且≥1,000 μg/日氟替卡松等效)骨折风险轻度升高(RR 1.10)。
- 该风险增加在男女之间无差异。
核心结论
- 长期高剂量ICS使用与慢阻肺患者髋部和上肢骨折风险轻度增加相关,且该风险增加在女性中并未更高。
研究设计与样本
- 基于魁北克医疗数据库的慢阻肺队列研究(1990-2005年),随访至2007年,采用嵌套病例对照分析,按年龄、性别和随访时间1:20匹配对照。
主要发现
- 队列共240,110例,平均随访5.3年,19,396例发生骨折,骨折率为15.2/1000人年。
- 任何ICS使用与骨折风险无关(RR 1.00;95%CI 0.97-1.03)。
- 使用ICS>4年且每日剂量≥1,000 μg氟替卡松等效时骨折风险增加(RR 1.10;95%CI 1.02-1.19)。
- 风险增加在男女之间无差异。
临床怎么用
- 对慢阻肺患者长期使用高剂量ICS时应评估骨折风险,尤其是疗程超过4年者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: It is uncertain whether long-term use of inhaled corticosteroids (ICSs), widely used to treat COPD, increases the risk of fracture, particularly in women, in view of the postmenopausal risks. We assessed whether long-term ICS use in patients with COPD increases the risk of hip or upper extremity fractures, and examined sex-related differences. METHODS: The Quebec health-care databases were used to form a cohort of patients with COPD over 1990 to 2005, followed until 2007 for the first hip or upper extremity fracture. In a nested case-control analysis, each case of fracture was matched with 20 control subjects on age, sex, and follow-up time. The adjusted rate ratio (RR) of fracture with ICS use, by duration and dose, was estimated using conditional logistic regression, with an interaction term to compare the risk in men and women. RESULTS: In the cohort of 240,110 subjects, 19,396 sustained a fracture during a mean 5.3 years (rate, 15.2 per 1,000 per year). Any use of ICSs was not associated with an increased rate of fracture (RR, 1.00; 95% CI, 0.97-1.03). The fracture rate was increased with > 4 years of ICS use at daily doses ≥ 1,000 μg in fluticasone equivalents (RR, 1.10; 95% CI, 1.02-1.19). This risk increase did not differ between men and women. CONCLUSIONS: Long-term ICS use at high doses is associated with a modest increase in the risk of hip and upper extremity fractures in patients with COPD. This dose-duration risk increase does not appear to be higher for women.
引用
- Gonzalez AV, Coulombe J, Ernst P, et al. Long-term Use of Inhaled Corticosteroids in COPD and the Risk of Fracture. Chest. 2017. PMID: 28716642. doi:10.1016/j.chest.2017.07.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。